Search Results 591-600 of 1731 for 批改网ai写作,ai写作的网文,ai画图的网址,下载ai 的网站,ai音乐生成网址,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

1. Baoan Ji, M.D., Ph.D. - Mayo Clinic Faculty Profiles

   He focuses on pancreatic inflammation and its role in pancreatic tumorigenesis. He has extensive experience using animal models. Dr. Ji's studies shed new ...

2. A Study to Evaluate the Safety and Effectiveness of Gantenerumab in Participants With Early Alzheimer's Disease (AD) - Mayo Clinic

   All participants must show evidence of beta-amyloid pathology. Eligible participants will be randomized 1:1 to receive either subcutaneous (SC) injection of ...

3. Brain tumor - Doctors and departments - Mayo Clinic

   Learn about our team of brain tumor doctors and surgeons who are researching new ways of diagnosing and treating this condition.

4. A Phase 1 Study Evaluating the Safety, PK, and Clinical Effects of PT-112 in Subjects With Advanced Solid Tumors

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. Short Duration 6Fed Sponge For EoE Patients - Mayo Clinic

   This research is being done to see if the investigators can use the cytosponge or esophacap (depending on availability) to determine if shorter duration SFED ( ...

6. Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET) - Mayo Clinic

   The purpose of this study is to collect longitudinal clinical and safety data for enrolled patients being evaluated for or treated with novel FDA-approved ...

7. Tools to evaluate treatment tolerability in older patients with sarcoma - Mayo Clinic

   We hypothesize that clinical screening tools and laboratory tests can help evaluate older patients (age 65 years and above) with advanced/metastatic sarcoma who ...

8. A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 Positive, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   This study will also evaluate other anti-tumor effects, tumor markers and pharmacokinetics (PK) of zolbetuximab, Nab-P and GEM. Participation eligibility.

9. Beth A. Cloud-Biebl, Ph.D., P.T., D.P.T. - Mayo Clinic Faculty Profiles

   Learn more about the research interests of Beth A. Cloud, P.T., Ph.D., D.P.T..

10. Vee Thao, Ph.D., M.S. - Mayo Clinic Faculty Profiles

    Viengneesee (Vee) Thao, Ph.D., M.S., is a Mayo Clinic health care delivery researcher who studies medical decision-making, including cost-effective ...